🇺🇸 FDA
Patent

US 12030970

Curable composition and stereolithographic resin composition comprising same

granted A61KA61K6/62A61K6/887

Quick answer

US patent 12030970 (Curable composition and stereolithographic resin composition comprising same) held by KURARAY CO., LTD. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KURARAY CO., LTD.
Grant date
Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K6/62, A61K6/887